Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States
- 27 May 2020
- journal article
- editorial
- Published by Hindawi Limited in International Journal of Clinical Practice
- Vol. 74 (9)
- https://doi.org/10.1111/ijcp.13561
Abstract
Coronavirus disease 2019 (COVID‐19) has rapidly spread to more than 200 countries and areas. As of May 11, 2020, more than 4 million cases have been confirmed globally and more than 280000 deaths have been recorded. In China, Italy and America, the mortality was 5.5% (4644/84451), 14.0% (30739/219814) and 6.1% (78652/1298287), respectively.1Funding Information
- National Natural Science Foundation of China (81870265)
This publication has 9 references indexed in Scilit:
- Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2Journal of the American Society of Nephrology, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissuesInfectious Diseases of Poverty, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2020
- Chronic kidney disease prevalence in the general population: heterogeneity and concerns: Table 1.Nephrology Dialysis Transplantation, 2015